SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roudy who wrote (428)3/6/1997 8:26:00 PM
From: I. Luttichuys   of 1762
 
Thanks Don, We've got more journals here than you can shake a stick at so I will be looking at that article.
I am expecting that recommendation to come out of Merrill Lynch soon enough.
I was talking to a physician in the halls here about this company and he took a look at the press releases and we continued this conversation this afternoon. I have to say it... out of all the stocks I own, this is the closest thing to a no-brainer I am currently looking at. All good news, unanimous "strong buys" and one from Hecht who was written up last year as the biotech picker of the year who, in that same article mentions IDEC, a monoclonal shown effective against NHL with side-effects far milder than chemo. Now... with chemo FDA approved inspite of its rather notorious side-effects, how hard is the FDA going to have to think before considering this drug a good thing? Notice that IDEC has filed for approval as a therapy for those who have failed other treatments... sure looks like they are being awful smart here. They are making in as easy as possible for the FDA to approve and I have to say, once again, that IDEC seems to think out every move they make. They will no doubt file for other applications later.
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News